Report Categories Report Categories

Report Categories

industry Category

All

Total: 3 records, 1 pages

Global Human Microbiome Based Drugs and Diagnostics Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 30 Jan 2024

date Medical Care

new_biaoQian Human Microbiome Based Drugs and Diagnostics

According to our (Global Info Research) latest study, the global Human Microbiome Based Drugs and Diagnostics market size was valued at USD 851.9 million in 2023 and is forecast to a readjusted size of USD 1647 million by 2030 with a CAGR of 9.9% during review period.

USD3480.00

Add To Cart

Add To Cart

Global Human Microbiome Based Drugs and Diagnostics Supply, Demand and Key Producers, 2023-2029

date 24 Feb 2023

date Medical Care

new_biaoQian Human Microbiome Based Drugs and Diagnostics

The modern approach involves exploiting the interaction between humans and the bacteria that live in or on the body to develop new drugs and therapies to treat chronic diseases such as diabetes. These microbiomes derived drugs help the physician in better diagnosis of the illness.

USD4480.00

Add To Cart

Add To Cart

Global Human Microbiome Based Drugs and Diagnostics Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 02 Jan 2023

date Medical Care

new_biaoQian Human Microbiome Based Drugs and Diagnostics

The modern approach involves exploiting the interaction between humans and the bacteria that live in or on the body to develop new drugs and therapies to treat chronic diseases such as diabetes. These microbiomes derived drugs help the physician in better diagnosis of the illness.

USD3480.00

Add To Cart

Add To Cart

According to our (Global Info Research) latest study, the global Human Microbiome Based Drugs and Diagnostics market size was valued at USD 851.9 million in 2023 and is forecast to a readjusted size of USD 1647 million by 2030 with a CAGR of 9.9% during review period.

USD3480.00

addToCart

Add To Cart

The modern approach involves exploiting the interaction between humans and the bacteria that live in or on the body to develop new drugs and therapies to treat chronic diseases such as diabetes. These microbiomes derived drugs help the physician in better diagnosis of the illness.

USD4480.00

addToCart

Add To Cart

The modern approach involves exploiting the interaction between humans and the bacteria that live in or on the body to develop new drugs and therapies to treat chronic diseases such as diabetes. These microbiomes derived drugs help the physician in better diagnosis of the illness.

USD3480.00

addToCart

Add To Cart